Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

414 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study.
Kropp FB, Smid MC, Lofwall MR, Wachman EM, Martin PR, Murphy SM, Wilder CM, Winhusen TJ. Kropp FB, et al. Among authors: murphy sm. J Subst Use Addict Treat. 2023 Jun;149:209030. doi: 10.1016/j.josat.2023.209030. Epub 2023 Apr 4. J Subst Use Addict Treat. 2023. PMID: 37023858 Free PMC article. Clinical Trial.
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.
Winhusen T, Lofwall M, Jones HE, Wilder C, Lindblad R, Schiff DM, Wexelblatt S, Merhar S, Murphy SM, Greenfield SF, Terplan M, Wachman EM, Kropp F, Theobald J, Lewis M, Matthews AG, Guille C, Silverstein M, Rosa C. Winhusen T, et al. Among authors: murphy sm. Contemp Clin Trials. 2020 Jun;93:106014. doi: 10.1016/j.cct.2020.106014. Epub 2020 Apr 27. Contemp Clin Trials. 2020. PMID: 32353544 Free PMC article.
The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation.
D'Onofrio G, Hawk KF, Herring AA, Perrone J, Cowan E, McCormack RP, Dziura J, Taylor RA, Coupet E, Edelman EJ, Pantalon MV, Owens PH, Martel SH, O'Connor PG, Van Veldhuisen P, DeVogel N, Huntley K, Murphy SM, Lofwall MR, Walsh SL, Fiellin DA. D'Onofrio G, et al. Among authors: murphy sm. Contemp Clin Trials. 2021 May;104:106359. doi: 10.1016/j.cct.2021.106359. Epub 2021 Mar 16. Contemp Clin Trials. 2021. PMID: 33737199 Free PMC article. Clinical Trial.
Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.
Fanucchi LC, Murphy SM, Surratt H, Kapadia SN, Walsh SL, Grubbs JA, Thornton AC, Nuzzo P, Lofwall MR. Fanucchi LC, et al. Among authors: murphy sm. Ther Adv Infect Dis. 2022 Jul 11;9:20499361221108005. doi: 10.1177/20499361221108005. eCollection 2022 Jan-Dec. Ther Adv Infect Dis. 2022. PMID: 35847566 Free PMC article.
Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis.
Lim S, Cherian T, Katyal M, Goldfeld KS, McDonald R, Wiewel E, Khan M, Krawczyk N, Braunstein S, Murphy SM, Jalali A, Jeng PJ, Rosner Z, MacDonald R, Lee JD. Lim S, et al. Among authors: murphy sm. J Subst Use Addict Treat. 2024 Mar;158:209254. doi: 10.1016/j.josat.2023.209254. Epub 2023 Dec 10. J Subst Use Addict Treat. 2024. PMID: 38072387
Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision.
Allen AA, Chen DT, Bonnie RJ, Ko TM, Suratt CE, Lee JD, Friedmann PD, Gordon M, McDonald R, Murphy SM, Boney TY, Nunes EV, O'Brien CP. Allen AA, et al. Among authors: murphy sm. J Subst Abuse Treat. 2017 Oct;81:66-72. doi: 10.1016/j.jsat.2017.07.015. Epub 2017 Aug 1. J Subst Abuse Treat. 2017. PMID: 28847457 Free PMC article. Clinical Trial.
414 results